Protara Therapeutics (NASDAQ:TARA) just reported results for the second quarter of 2024.
- Protara Therapeutics reported earnings per share of -45 cents. This was above the analyst estimate for EPS of -80 cents.
- The company did not report any revenue for the quarter.